German Chemical-Pharmaceutical Industry Sales and R&D Forecast to Grow in 2018
German chemical revenues rise, as number of R&D employees declines
Tanya Samazan has written about the analytical and life science instrument industry for over 15 years. She has conducted hundreds of in-depth interviews with industry leaders and participants for IBO. She has written extensively about major companies, business trends, end-markets and technology developments, providing insight and analysis about industry prospects and developments. Her comments have also appeared in Chemical & Engineering News. Tanya is a graduate of UCLA and previously worked at the UCLA Law Review.
German chemical revenues rise, as number of R&D employees declines
Merck, Johnson & Johnson significantly increase R&D spending in first half of year
Ortho Clinical Diagnostics emerges as big winner at IMV ServiceTrak Awards
Agilent, Bruker keeping busy with acquisitions in 2018
Lab instruments affected in US/China tariffs
Private sector now leading R&D funding, as federal funding continues decline
Acquisition provides Illumina with strong NGS data processing capabilities
IBO spotlights DKSH’s work across Asia
Axcend’s new HPLC product boasts portability, high-sensitivity
Nordic countries continue fostering life science sectors
Syncell: Advancing Spatial Proteomics
June 30, 2025 3:41 pm
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
May 29, 2025 1:38 pm
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.